Average Co-Inventor Count = 4.49
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Probiodrug Ag (53 from 73 patents)
2. Prosidion Limited (4 from 16 patents)
3. Other (2 from 832,880 patents)
4. Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v. (2 from 4,822 patents)
5. Osi Pharmaceuticals, Inc. (2 from 118 patents)
6. Forschungszentrum Juelich Gmbh (1 from 204 patents)
7. Vivoryon Therapeutics N.v. (1 from 5 patents)
8. Vivoryon Therapeutics Ag (1 from 1 patent)
9. Forschungszentrum Julich Gmbh (303 patents)
10. Royalty Pharma Collection Trust (0 patent)
66 patents:
1. 12378186 - Inhibitors of meprin α and β
2. 11703511 - Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereof
3. 11186572 - Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitis
4. 10975019 - Inhibitors of meprin α and β
5. 9676843 - Uses of antibodies directed against amyloid-β
6. 9657089 - Diagnostic antibody assay
7. 9650362 - Inhibitors
8. 9611296 - Peptides that bind to amino-truncated amyloid-beta-peptide and use of said peptides
9. 9610368 - Radiolabelled glutaminyl cyclase (QC) inhibitors and uses of same
10. 9512115 - Inhibitors
11. 9462793 - Mouse carrying a knock-out mutation of the Qpct-gene
12. 9277737 - Mouse models carrying a knock-out mutation of the QPCTL-gene
13. 9181233 - Inhibitors of glutaminyl cyclase
14. 9173885 - Inhibitors
15. 9157918 - Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)